Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

6.03
Delayed Data
As of Jul 15
 +0.42 / +7.49%
Today’s Change
3.22
Today|||52-Week Range
11.34
+64.31%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Corvus Pharmaceuticals Inc have a median target of 11.50, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +90.71% increase from the last price of 6.03.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Corvus Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.43
Sales
$0.00
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.13%
 
 
 
 
 
 
Growthannually 1.61%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.